From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

Brooks Nader opens up about GLP-1 weight loss drugs and says women from all backgrounds reached out to her after her reality ...

For adults with type 2 diabetes mellitus (T2DM), glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy is associated ...

Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

Surging demand for Ozempic and other GLP-1 drugs is adding up for some Minnesota employers. Why it matters: The popular ...

Constellation Brands, Inc. (NYSE:STZ) ranks among the best sin stocks to buy in 2026. On November 21, Piper Sandler cut its ...

A local telehealth startup founded by a former wealth management executive and a health-care veteran is targeting busy ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for ...